Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$671M |
| 2 |
McDonald's
MCD
|
+$636M |
| 3 |
TSMC
TSM
|
+$515M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$465M |
| 5 |
Colgate-Palmolive
CL
|
+$458M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.45% |
| 2 | Healthcare | 11.94% |
| 3 | Consumer Discretionary | 11.58% |
| 4 | Consumer Staples | 10.68% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Delek US
DK
$3.92B
| $74.8M | 0.2% |
+2,599,200
| New | +$91.2M |
|
102
M&T Bank
MTB
$36.4B
| $74.6M | 0.2% |
+667,550
| New | +$68.8M |
|
|
SIX
103
DELISTED
Six Flags Entertainment Corp.
SIX
| $73.7M | 0.19% |
+2,095,500
| New | +$78.2M |
|
104
Franklin Resources
BEN
$16.9B
| $73.6M | 0.19% |
+1,623,600
| New | +$82.7M |
|
105
Starbucks
SBUX
$122B
| $73.2M | 0.19% |
+2,236,200
| New | +$69.5M |
|
106
Broadcom
AVGO
$1.98T
| $71.6M | 0.19% |
+19,166,000
| New | +$66.8M |
|
107
Flowers Foods
FLO
$1.52B
| $70.9M | 0.19% |
+3,216,063
| New | +$70.5M |
|
|
DFS
108
DELISTED
Discover Financial Services
DFS
| $70M | 0.18% |
+1,470,300
| New | +$67.5M |
|
109
Intercontinental Exchange
ICE
$84.9B
| $69.5M | 0.18% |
+1,954,000
| New | +$65.5M |
|
110
Dillards
DDS
$10.1B
| $68.9M | 0.18% |
+840,700
| New | +$71.1M |
|
|
CTXS
111
DELISTED
Citrix Systems Inc
CTXS
| $68.9M | 0.18% |
+1,432,604
| New | +$73.9M |
|
112
Travelers Companies
TRV
$78.3B
| $68.6M | 0.18% |
+858,872
| New | +$72.2M |
|
113
Healthpeak Properties
DOC
$14.1B
| $68M | 0.18% |
+1,644,145
| New | +$75M |
|
114
GSK
GSK
$102B
| $67.8M | 0.18% |
+1,086,000
| New | +$68.9M |
|
115
Oil States International
OIS
$532M
| $66.8M | 0.18% |
+1,262,100
| New | +$64.4M |
|
|
SHPG
116
DELISTED
Shire pic
SHPG
| $65.6M | 0.17% |
+690,112
| New | +$64.7M |
|
|
VGR
117
DELISTED
Vector Group Ltd.
VGR
| $64.9M | 0.17% |
+7,941,804
| New | +$64.3M |
|
118
Commault Systems
CVLT
$5.78B
| $64.7M | 0.17% |
+851,900
| New | +$62.7M |
|
|
GAP
119
The Gap Inc
GAP
$7.55B
| $64.4M | 0.17% |
+1,543,600
| New | +$60.8M |
|
120
Whirlpool
WHR
$2.84B
| $64M | 0.17% |
+559,357
| New | +$67.8M |
|
|
APC
121
DELISTED
Anadarko Petroleum
APC
| $63.9M | 0.17% |
+743,800
| New | +$64M |
|
|
PCP
122
DELISTED
PRECISION CASTPARTS CORP
PCP
| $63.6M | 0.17% |
+281,400
| New | +$57M |
|
123
Teradata
TDC
$2.5B
| $63.2M | 0.17% |
+1,258,800
| New | +$67.8M |
|
124
Cognizant
CTSH
$26.4B
| $62.8M | 0.16% |
+2,006,352
| New | +$66.7M |
|
125
Johnson & Johnson
JNJ
$626B
| $62.5M | 0.16% |
+727,400
| New | +$61.7M |
|
Similar funds
Jim Simons's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Jim Simons, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.
Its largest position is Eli Lilly: 12,326,205 shares worth $605M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
- Jim Simons's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
- Jim Simons disclosed 2,756 positions in Q2 2013, its first 13F filing on record.
Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.